Cite
Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.
MLA
Zhang, Daye, et al. “Dexamethasone and Lenvatinib Inhibit Migration and Invasion of Non-Small Cell Lung Cancer by Regulating EKR/AKT and VEGF Signal Pathways.” Experimental & Therapeutic Medicine, vol. 19, no. 1, Jan. 2020, pp. 762–70. EBSCOhost, https://doi.org/10.3892/etm.2019.8225.
APA
Zhang, D., Zhang, Y., Cai, Z., Tu, Y., & Hu, Z. (2020). Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways. Experimental & Therapeutic Medicine, 19(1), 762–770. https://doi.org/10.3892/etm.2019.8225
Chicago
Zhang, Daye, Yongxiang Zhang, Zeyuan Cai, Ying Tu, and Zhansong Hu. 2020. “Dexamethasone and Lenvatinib Inhibit Migration and Invasion of Non-Small Cell Lung Cancer by Regulating EKR/AKT and VEGF Signal Pathways.” Experimental & Therapeutic Medicine 19 (1): 762–70. doi:10.3892/etm.2019.8225.